{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:27:09Z","timestamp":1765268829631},"reference-count":8,"publisher":"Japanese Urological Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2021,4,20]]},"DOI":"10.5980\/jpnjurol.112.109","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T22:13:24Z","timestamp":1650406404000},"page":"109-112","source":"Crossref","is-referenced-by-count":2,"title":["INTERSTITIAL NEPHRITIS CAUSED BY IPILIMUMAB AND NIVOLUMAB COMBINATION THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A CASE REPORT"],"prefix":"10.5980","volume":"112","author":[{"given":"Makoto","family":"Ishii","sequence":"first","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Takezawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohide","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kiuchi","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Nonomura","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","unstructured":"1) \u85ac\u5264\u6027\u814e\u969c\u5bb3\u306e\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u6210\u59d4\u54e1\u4f1a\u7de8: \u85ac\u5264\u6027\u814e\u969c\u5bb3\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3. \u65e5\u814e\u4f1a\u8a8c, 58(4), 477-555, 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Frank BC, Kristen AM, Megan LT, Kenneth MR, Melanie PH, Julie RB, Dung TL, Evan JL, Ilya GG, Jedd W, Lynn DC, Paul F, Michael BS, Sarah AZ, Stephen H, Patrock AO, Michifumi Y and David EL: Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int., 90, 638-647, 2016.","DOI":"10.1016\/j.kint.2016.04.008"},{"key":"3","unstructured":"3) \u5bae\u8feb \u8cb4\u6b63, \u5185\u85e4 \u9686\u4e4b, \u5009\u8107 \u58ee, \u5c0f\u7530\u5ddd \u8aa0\u6cbb, \u6e05\u6c34 \u512a\u4f73, \u5c0f\u5ddd \u8cb4\u5f66, \u4e32\u7530 \u5409\u751f, \u539f \u91cd\u96c4, \u571f\u4e95 \u76db\u535a, \u6b63\u6728 \u5d07\u751f: \u30cb\u30dc\u30eb\u30de\u30d6\u306b\u3088\u308b\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u6cbb\u7642\u4e2d\u306b\u6025\u6027\u5c3f\u7d30\u7ba1\u9593\u8cea\u6027\u814e\u708e\u3092\u304d\u305f\u3057\u305f1\u4f8b. \u65e5\u814e\u4f1a\u8a8c, 60(2), 156-164, 2018."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Uchida A, Watanabe M, Nawata A, Ikari Y, Sasaki M, Shigemoto K, Hisano S and Nakashima H: Tubulointerstitial nephritis as adverse effect of programmed cell death 1 inhibitor, nivolumab, shows distinct histological findings. CEN Case Rep, 6, 169-174, 2017.","DOI":"10.1007\/s13730-017-0269-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) \u9580\u91ce \u5cb3\u53f2: \u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u306b\u3088\u308b\u514d\u75ab\u95a2\u9023\u526f\u4f5c\u7528\u306e\u5b9f\u969b. Jpn. Clin. Immunol., 40(2), 83-89, 2017.","DOI":"10.2177\/jsci.40.83"},{"key":"6","unstructured":"6) Kathryn CA, Laura M, Niamh L, Hira R, Edouard A, Andy N, Gala MB, Roberto F, Victoria L, Lizza ELH, Joshua KS, Caroline C, Andrew JP, Darragh H, Jamie EC, David P, Gregory JR, Benjamin B and Matthew DH: Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 79, 6, 2018."},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Audrey S, Jean MM, Anne LV, J\u00e9rome LP, Michael C, Audrey L, Geoffray C, Aurore V, Ariane L, Andr\u00e9a V, Antoine H, St\u00e9phane C, Aur\u00e9lien M, Christophe M and Olivier L: Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer. JAMA Oncology, 5(9), 1310-1317, 2019.","DOI":"10.1001\/jamaoncol.2019.1022"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pollack MH, Betof A, Dearden H, Rapazzo K, Valentine I, Brohl AS, Ancell KK, Long GV, Menzies AM, Eroglu Z, Johnson DB and Shoushtari AN: Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Annals of Oncology, 29(1), 250-255, 2018.","DOI":"10.1093\/annonc\/mdx642"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/112\/2\/112_109\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T05:15:45Z","timestamp":1650690945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/112\/2\/112_109\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.112.109","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]}}}